Not Yet RecruitingNot Applicable

Diagnostic Imaging of Vascular Malformations Using MSOT and ULM

Germany15 participantsStarted 2025-08-01

Plain-language summary

This clinical study evaluates the efficacy and accuracy of Multispectral Optoacoustic Tomography (MSOT) and Ultrasound Localization Microscopy (ULM) for imaging and diagnosing vascular malformations (venous, arteriovenous, lymphatic). The study aims to enhance diagnostic precision and improve treatment planning through advanced non-invasive imaging techniques.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Confirmed vascular malformations (arteriovenous, venous, or lymphatic). * ≥18 years old and able to give their consent Exclusion Criteria: * No imaging for diagnostic confirmation has been performed or is planned. * Lack of written consent * \<18 years old * Safety concerns of the study physician (a patient with physical, psychological, or psychiatric conditions that, in the opinion of the study physician, could compromise the patient's safety or the quality of the data, thereby making the patient an unsuitable candidate for the study).

What they're measuring

Quantitative signal of total hemoglobin (HbT), oxygenated hemoglobin (HbO2), deoxygenated hemoglobin (Hb), and oxygen saturation (mSO2).

Timeframe: through study completion, an average of 1 year

Quantification of perfusion dynamics in the respective vessel.

Timeframe: through study completion, an average of 1 year

Trial details

NCT IDNCT06994260

SponsorUniversity Hospital Erlangen

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-02-01

Contact for this trial

Ulrich Rother, PD Dr. med.

+4991318542028 ulrich.rother@uk-erlangen.de

View on ClinicalTrials.gov More Vascular Malformation trials